Lin J H, Chremos A N, Kanovsky S M, Schwartz S, Yeh K C, Kann J
Merck Sharp and Dohme Research Laboratories, West Point, PA 19486.
Br J Clin Pharmacol. 1987 Oct;24(4):551-3. doi: 10.1111/j.1365-2125.1987.tb03211.x.
The effect of a high potency antacid and food on the bioavailability of famotidine was studied in 17 healthy volunteers in an open randomized three-way cross-over trial. After an overnight fast, famotidine was administered to each subject as follows: 40 mg famotidine orally alone; 40 mg orally with antacid; and 40 mg orally with a standard breakfast. Coadministration of the antacid caused a small but significant reduction in the maximum plasma concentration (Cmax) of famotidine from 81.1 +/- 54.2 to 60.8 +/- 21.6 ng ml-1 (P less than 0.05) and a small decrease in the area under plasma concentration-time curve [AUC] from 443.3 +/- 249.2 to 355.0 +/- 125.1 ng ml-1 h (P greater than 0.05). However, there was only a minimal effect of food on these parameters; the Cmax and [AUC] were 81.6 +/- 29.6 ng ml-1 and 434.8 +/- 145.9 ng ml-1 h, respectively.
在一项开放性随机三交叉试验中,对17名健康志愿者研究了高效抗酸剂和食物对法莫替丁生物利用度的影响。经过一夜禁食后,对每位受试者按如下方式给予法莫替丁:单独口服40mg法莫替丁;与抗酸剂一起口服40mg;与标准早餐一起口服40mg。抗酸剂的共同给药使法莫替丁的最大血浆浓度(Cmax)从81.1±54.2降至60.8±21.6ng/ml-1(P<0.05),有小幅但显著的降低,并且血浆浓度-时间曲线下面积[AUC]从443.3±249.2降至355.0±125.1ng/ml-1 h(P>0.05),有小幅下降。然而,食物对这些参数仅有极小的影响;Cmax和[AUC]分别为81.6±29.6ng/ml-1和434.8±145.9ng/ml-1 h。